Despite previous findings demonstrating the beneficial effects of increased expression of HMOX1 on NAFLD development, and progression in experimental settings as well as a human study on Taiwanese pediatric NAFLD patients, our observations in adult patients with a substantial proportion of advanced liver disease did not confirm these data. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.